Overcoming Resistance to Checkpoint Inhibitors: Natural Killer Cells in Non-Small Cell Lung Cancer

Overcoming Resistance to Checkpoint Inhibitors: Natural Killer Cells in Non-Small Cell Lung Cancer

Immune checkpoint inhibitors (ICIs) have revolutionized cancer treatments over the last 10 years, with even increasing indications in many neoplasms. Non-small cell lung cancer (NSCLC) is considered highly immunogenic, and ICIs have found a wide set of applications in this area, in both early and ad...

Full description

Bibliographic Details
Main Authors: Maria Gemelli, Douglas M. Noonan, Valentina Carlini, Giuseppe Pelosi, Massimo Barberis, Riccardo Ricotta, Adriana Albini
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-05-01
Series:Frontiers in Oncology
Subjects:
natural killer
non-small cell lung cancer
tumor microenvironment
checkpoint inhibitors
inflammation
angiogenesis
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.886440/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2022.886440/full

Similar Items